Clinical Trial

Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a single-center, prospective, single-arm study evaluating the safety and feasibility of total pancreatectomy with islet autotransplantation (TPIAT) in carefully selected adult patients with periampullary neoplasms who are considered at high risk for postoperative pancreatic fistula after pancreaticoduodenectomy. Eligible patients will undergo open or robotic TPIAT as part of the patient's surgical management. Perioperative outcomes, postoperative complications, metabolic outcomes, and early oncologic outcomes will be collected prospectively as part of routine clinical care and analyzed to assess the safety and feasibility of this approach.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2026-01-14; most recent amendment 2026-06-26.
Trial Details
NCT Number NCT07360119
Lead Sponsor Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Conditions Periampullary Neoplasms, Pancreatic Cancer
Enrollment 30 participants
Start Date 2026-08-01
Primary Completion 2031-02-01 (estimated)
Study Completion 2031-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-29